粘液性乳腺癌的临床研究进展  

Clinical research progress of mucinous breast cancer

作　　者：张锐(综述)[1] 李志高(审校)[1] ZHANG Rui;LI Zhigao(Harbin Medical University Cancer Hospital,Harbin 150081,China)

机构地区：[1]哈尔滨医科大学附属肿瘤医院,哈尔滨150081

出　　处：《实用肿瘤学杂志》2020年第4期377-381,共5页Practical Oncology Journal

摘　　要：粘液性乳腺癌(Mucinous breast carcinoma,MBC)是一种来自乳房的侵袭性肿瘤。其不是乳腺癌的常见类型,关于乳腺粘液性乳腺癌的文献比较少见。基于肿瘤的细胞构成,粘液性乳腺癌分为两种亚型单纯型乳腺粘液癌(Pure mucinous breast carcinoma,PMBC)和混合型乳腺粘液癌(Mixed mucinous breast carcinoma,MMBC)。本文将对粘液性乳腺癌的临床特征、免疫表型、基因组学、鉴别诊断、治疗和预后做一综述。Mucinous breast cancer(MBC)is an aggressive tumor from the breast.It is not a common type of breast cancer,and the literature about mucinous breast cancer is relatively rare.Based on the cellular composition of the tumor,mucinous breast cancer is divided into two subtypes pure type mucinous cancer(PMBC)and mixed type mucinous breast cancer(MMBC).This article reviews the clinical characteristics,immunophenotype,genomics,differential diagnosis,treatment,and prognosis of mucinous breast cancer.

关 键 词：粘液性乳腺癌 临床特征 免疫表型 鉴别诊断 治疗 

分 类 号：R737.9[医药卫生—肿瘤]